Acadian Asset Management LLC Natera, Inc. Transaction History

Acadian Asset Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$43.4 - $62.52 $19,703 - $28,384	454 New	454 $20,000
Q3 2022 Nov 14, 2022	BUY	$36.93 - $56.68 $64,664 - $99,246	1,751 New	1,751 $76,000
Q4 2021 Feb 10, 2022	SELL	$86.26 - $119.0 $283,019 - $390,439	-3,281 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $328,657 - $414,587	3,281 New	3,281 $363,000
Q1 2021 May 11, 2021	SELL	$91.47 - $124.36 $31,374 - $42,655	-343 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$66.66 - $111.74 $22,864 - $38,326	343 New	343 $34,000
Q1 2020 May 11, 2020	SELL	$17.27 - $40.17 $45,644 - $106,169	-2,643 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$32.1 - $40.4 $84,840 - $106,777	2,643 New	2,643 $89,000

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.